More study data available!
Data has been uploaded for 3 studies including:
- Monoclonal antibody characterization studies:
- Ho study comparing ibalizumab and ibalizumab variants,
- Haynes study comparing monomeric and dimeric recombinant IgAs, such as CH31, and
- Animal studies:
- Feinberg study comparing eOD-GT8 60mer + AS01 B adjuvant dosing regimens in rabbits.
Click on the study page links below for Protocol Team reports, data summaries, and more details about the studies.
Data was uploaded for the following studies:
|
Name & Description |
Data Added |
Type |
PI |
Strategy |
|
CAVD 353 is an immunogenicity study to evaluate the neutralization activity of the monoclonal antibody, Ibalizumab, and Ibalizumab variants. |
NAB MAB |
Antibody Screening |
David Ho |
Prophylactic neutralizing Ab |
|
CAVD 425 is an immunogenicity study to evaluate the neutralization activity of monomeric and dimeric recombinant IgAs (and IgG controls). |
NAB MAB |
Antibody Screening |
Bart Haynes |
Prophylactic neutralizing Ab |
|
CAVD 679 is a preclinical study in rabbits evaluating repeated dosing of eOD-GT8 60mer/AS01 B adjuvant. |
BAMA |
Pre-Clinical Non-NHP |
Mark Feinberg |
Protein and peptide vaccines |